Treating to target in rheumatoid arthritis: Challenges and opportunities

Eric M Ruderman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The treat to target approach to managing therapy in rheumatoid arthritis was only just formally proposed in 2010, yet it is clearly here to stay. While the original recommendations were based on a limited set of published data, subsequent studies have explored the role of the treat to target approach in a variety of clinical settings and have confirmed its value. Despite this, additional data is needed, and challenges still remain in the widespread implementation of the treat to target strategy. Some of these challenges are at the patient level, some are at the physician level, and some are at the system level. The identification of these challenges is in itself an opportunity to improve the treat to target paradigm in order to maximize the outcomes of patients with rheumatoid arthritis.

Original languageEnglish (US)
Pages (from-to)214-217
Number of pages4
JournalBulletin of the Hospital for Joint Diseases
Volume71
Issue number3
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Surgery
  • Rheumatology
  • Orthopedics and Sports Medicine

Fingerprint Dive into the research topics of 'Treating to target in rheumatoid arthritis: Challenges and opportunities'. Together they form a unique fingerprint.

Cite this